Study of a New Medication for the Treatment of HIV

What we are studying

The purpose of this study is to evaluate if Tenofovir Alafenamide is effective against HIV-1 when added to a subject’s current antiretroviral regimen that is no longer effective to treat HIV-1. Then, the study will evaluate if subjects can safely switch to an experimental drug without increasing the amount of virus in their blood.

Who we are studying

  • Men and Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 18+

Eligibility Criteria

  • HIV-1 infection with a viral load between 500 and 100000
  • Taking antiviral medications that are not currently working

What is involved

  • 4 clinic visits during Part 1
  • 11 clinic visits during Part 2
  • At each visit you will have a physical exam with vital signs; blood and urine will be collected for lab tests; and you will be asked about changes in your medications and any side effects you have experienced.

Contact Information

Study Coordinator
Liby Mosley
Email
limosley@wakehealth.edu
Phone
336-716-3266
Principal Investigator
Dr. Aimee Wilkin

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.